Skip to main content
Livermore
Livermore
ZHEN

Ensign Peak Advisors, Inc

SEC CIK
0001454984
Latest filing
Aug 14, 2026

PCVX holding history

Vaxcyte, Inc. in every 13F filed by Ensign Peak Advisors, Inc, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

PCVX overviewAll 13F holders of PCVXFull Q2 2026 holdings

Shares (Q2 2026)
381,686
Value
$22.2M
% of portfolio
<0.1%
Quarters held
20
Since Q1 2021
Holdings of PCVX by Ensign Peak Advisors, Inc, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 2026381,686$22.2M<0.1%−64,217−14.4%ReducedHolders
Q1 2026445,903$25.9M<0.1%−81,785−15.5%ReducedHolders
Q4 2025527,688$24.3M<0.1%−1,165−0.2%ReducedHolders
Q3 2025528,853$19.0M<0.1%−3,350−0.6%ReducedHolders
Q2 2025532,203$17.3M<0.1%−211,957−28.5%ReducedHolders
Q1 2025744,160$28.1M0.1%+158,032+27.0%AddedHolders
Q4 2024586,128$48.0M0.1%+39,293+7.2%AddedHolders
Q3 2024546,835$62.5M0.1%+84,153+18.2%AddedHolders
Q2 2024462,682$34.9M0.1%−13,018−2.7%ReducedHolders
Q1 2024475,700$32.5M0.1%+114,569+31.7%AddedHolders
Q4 2023361,131$22.7M<0.1%+85,345+30.9%AddedHolders
Q3 2023275,786$14.1M<0.1%00.0%UnchangedHolders
Q2 2023275,786$13.8M<0.1%+26,900+10.8%AddedHolders
Q1 2023248,886$9.33M<0.1%+350+0.1%AddedHolders
Q4 2022248,536$11.9M<0.1%+144,961+140.0%AddedHolders
Q3 2022103,575$2.49M<0.1%+28,665+38.3%AddedHolders
Q2 202274,910$1.63M<0.1%+39,010+108.7%AddedHolders
Q1 202235,900$867.0K<0.1%+34,480+2,428.2%AddedHolders
Q4 20211,420$34.0K<0.1%+1,420NewHolders
Q2 20210$00.0%−20,873−100.0%Sold outHolders
Q1 202120,873$412.0K<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.